IEFM
ADPT icon

IQ EQ Fund Management’s Adaptive Biotechnologies ADPT Stock Holding History

IQ EQ Fund Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
77,265
+3,335
+5% +$51.1K 0.11% 165
2026
Q1 		$1.03M Buy
73,930
+9,671
+15% +$154K 0.08% 210
2025
Q4 		$1.04M Sell
64,259
-2,500
-4% -$40.8K 0.07% 209
2025
Q3 		$999K Buy
66,759
+16,655
+33% +$203K 0.07% 207
2025
Q2 		$584K Buy
50,104
+691
+1% +$6.28K 0.05% 251
2025
Q1 		$367K Buy
49,413
+13,892
+39% +$107K 0.04% 255
2024
Q4 		$213K Buy
35,521
+9,945
+39% +$54.8K 0.03% 269
2024
Q3 		$131K Buy
25,576
+5,826
+29% +$25.4K 0.01% 310
2024
Q2 		$71.5K Buy
+19,750
New +$62.7K 0.01% 305

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IQ EQ Fund Management's ADPT Position: Q2 2026 in Review

IQ EQ Fund Management increased its Adaptive Biotechnologies (ADPT) stake by 4.5% in Q2 2026, buying an estimated $51.1K and bringing the position to 77,265 shares worth $1.66M. The position accounts for 0.11% of the portfolio, ranked #165.

IQ EQ Fund Management first reported a position in ADPT in Q2 2024 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • IQ EQ Fund Management held 77,265 shares of Adaptive Biotechnologies worth $1.66M as of Q2 2026.
  • IQ EQ Fund Management bought 3,335 Adaptive Biotechnologies shares in Q2 2026, an estimated $51.1K.
  • Adaptive Biotechnologies made up 0.11% of IQ EQ Fund Management's portfolio in Q2 2026, its #165 holding.
  • IQ EQ Fund Management first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 9 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.